The Wistar Institute appoints Dr. Jozef Madzo as assistant professor and director of Bioinformatics.
News — PHILADELPHIA — (July 1, 2024) —is pleased to announce the appointment of Jozef Madzo, Ph.D., to the faculty as an assistant professor and director of Bioinformatics. Dr. Madzo will lead and oversee Wistar’s bioinformatics projects & initiatives across a variety of advanced biomedical research programs.
As an experienced bioinformatician and established researcher, Dr. Madzo brings decades of experience in large-scale biomedical data analysis for research applications, including analysis of whole-genome, transcriptional, and epigenetic datasets. At Wistar, Dr. Madzo will oversee the bioinformatics pipeline that has become increasingly relevant to foundational biomedical research.
“The Wistar Institute is pleased to welcome Dr. Madzo to our faculty as Wistar’s Director of Bioinformatics,” said , Wistar president and CEO, director of the , and the Robert and Penny Fox Distinguished Professor. “More and more, foundational biomedical research requires robust bioinformatics support, and we at Wistar are excited to have the expertise and leadership of Dr. Madzo to advance our bioinformatics endeavors.”
The newly established Madzo Lab at Wistar will continue Dr. Madzo’s work in the epigenetics of cancer, which is the study of how genes’ expression can impact cancer’s characteristics. Specifically, Dr. Madzo studies how patterns in an epigenetic factor called DNA methylation — which refers to when methyl molecules are chemically incorporated DNA’s constituent molecules — affect cancer development & progression.
“I’ve always admired the exciting work at The Wistar Institute, so it’s a special opportunity and honor to join such stellar researchers,” said Dr. Madzo. “I look forward to joining my colleagues in their daily fight against cancer and disease by providing them with collaborative bioinformatics support.”
ABOUT THE WISTAR INSTITUTE
is the nation’s first independent nonprofit institution devoted exclusively to foundational biomedical research and training. Since 1972, the Institute has held National Cancer Institute (NCI)-designated Cancer Center status. Through a culture and commitment to biomedical collaboration and innovation, Wistar science leads to breakthrough early-stage discoveries and life science sector start-ups. Wistar scientists are dedicated to solving some of the world’s most challenging problems in the field of cancer and immunology, advancing human health through early-stage discovery and training the next generation of biomedical researchers. .
RSS